ヤスカワ クミ
  安川 久美
   所属   医学部 医学科(附属八千代医療センター)
   職種   准教授
論文種別 症例報告
言語種別 英語
査読の有無 査読あり
表題 Panton-Valentine leukocidin-positive novel sequence type 5959 community-acquired methicillin-resistant Staphylococcus aureus meningitis complicated by cerebral infarction in a 1-month-old infant.
掲載誌名 正式名:Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
略  称:J Infect Chemother
ISSNコード:14377780/1341321X
掲載区分国外
巻・号・頁 27(1),pp.103-106
著者・共著者 Nozomu Oshima, Hiromichi Hamada, Shoko Hirose, Kyohei Shimoyama, Makoto Fujimori,
Takafumi Honda, Kumi Yasukawa, Naruhiko Ishiwada, Misako Ohkusu, Jun-ichi Takanashi
発行年月 2021/01
概要 Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) has become a pathogen of major importance in pediatric patients. CA-MRSA can cause skin and soft tissue infection in children and young active adults with no predisposing factors, and life-threatening infections such as meningitis or necrotizing pneumonia have been reported. We report here a case of CA-MRSA meningitis complicated by acute left middle cerebral artery (MCA) infarction and necrotizing pneumonia in a previously healthy 1-month-old Vietnamese boy. He was firstly treated with vancomycin, but changed to linezolid because of persistent fever and low vancomycin trough level. He recovered successfully with residual right-sided hemiparesis. The mode of transmission of CA-MRSA and the mechanism of cerebral infarction (thrombotic or embolic) were unknown. The isolate was genotyped as staphylococcal cassette chromosome (SCC) mec type V with a novel sequence type (ST) 5959 harboring the Panton-Valentine leukocidin (PVL) gene. ST 5959 is a double locus variant of ST 59, which is a major PVL-positive CA-MRSA strain isolated in invasive disease in Asian countries. This case report may serve as a warning about the dissemination of PVL-positive CA-MRSA in and around Japan, with the possibility of causing serious life-threatening disease. The potential of linezolid for the treatment of MRSA meningitis as one of the alternative MRSA therapeutic drugs is also discussed.
DOI 10.1016/j.jiac.2020.09.011
PMID 32988732